The aim of our study was to retrospectively confirm the diagnostic importance of CALR mutations in JAK2 V617F-negative patients with suspected MPN based on clinical and/or laboratory parameters who were referred to the Department of Haematology by general practitioners. Here, JAK2 is linked to myeloproliferative neoplasm.